Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 523 of 1,261

  1. US 10179114

    Phenolic coatings and methods of making and using same

    Northwestern University · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  2. US 10179155

    Phosphodiesterase-4 inhibiting phytochemical compositions

    Nature's Sunshine Products, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  3. US 10179119

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  4. US 10179112

    Viral vector nanocapsule for targeting gene therapy and its preparation

    The Regents of the University of California · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  5. US 10179792

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  6. US 10179819

    Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  7. US 10179173

    Semi-solid delivery systems

    Regents of the University of Minnesota · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  8. US 10179783

    Tetrahydropyridopyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  9. US 2019008774

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME

    BIAL PORTELA & Cª S A [PT] · Granted Jan 10, 2019 · Expires Jan 5, 2039

    granted

  10. US 10172920

    Sleep apnea treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  11. US 10173074

    Cancer stem cell vaccination and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  12. US 10172864

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  13. US 10173989

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  14. US 10174085

    Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  15. US 10172937

    Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

    Five Prime Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  16. US 10172836

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  17. US 10172933

    Mosaic vaccines for serotype a foot-and-mouth disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  18. US 10172932

    Ebola virus disease vaccine taking human replication deficient adenovirus as vector

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  19. US 10172911

    Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  20. US 10172930

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  21. US 10172908

    Method for treating cognitive dysfunction

    ARIZONA BOARD OF REGENTS FOR THE UNIVERSITY OF ARIZONA · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  22. US 10174318

    Antisense oligonucleotide compositions

    Ionis Pharmaceuticals, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  23. US 10172831

    Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them

    The Regents of the University of California · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  24. US 10172789

    Compositions for transdermal delivery of mTOR inhibitors

    PALVELLA THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.